Singular Genomics Systems Inc

General ticker "OMIC" information:

  • Sector: Health Care
  • Industry: Life Sciences Tools & Services
  • Capitalization: $49.7M

Singular Genomics Systems Inc follows the US Stock Market performance with the rate: 31.0%.

Estimated limits based on current volatility of 0.3%: low 19.96$, high 20.09$

Factors to consider:

  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [5.15$, 18.32$]
  • 2024-12-30 to 2025-12-30 estimated range: [3.01$, 11.13$]

Financial Metrics affecting the OMIC estimates:

  • Negative: Non-GAAP EPS, $ of -39.34 <= 0.03
  • Negative: Operating cash flow per share per price, % of -71.31 <= 1.69
  • Negative: Industry inventory ratio change (median), % of 1.39 > 0.50
  • Negative: negative Operating income
  • Negative: negative Net income

Similar symbols

Short-term OMIC quotes

Long-term OMIC plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.77MM $2.91MM
Operating Expenses $61.28MM $94.25MM $105.71MM
Operating Income $-61.28MM $-93.49MM $-102.80MM
Non-Operating Income $-37.49MM $2.61MM $7.98MM
Interest Expense $0.85MM $0.76MM $1.10MM
R&D Expense $32.66MM $46.20MM $47.76MM
Income(Loss) $-98.77MM $-90.88MM $-94.82MM
Taxes $0.00MM $-2.61MM $0.00MM
Profit(Loss)* $-98.89MM $-88.27MM $-94.82MM
Stockholders Equity $336.17MM $260.32MM $179.01MM
Inventory $3.01MM $18.22MM $13.57MM
Assets $355.65MM $327.98MM $265.47MM
Operating Cash Flow $-51.70MM $-87.09MM $-73.65MM
Capital expenditure $4.86MM $6.02MM $0.97MM
Investing Cash Flow $-130.86MM $-39.57MM $13.81MM
Financing Cash Flow $372.13MM $0.90MM $0.70MM
Earnings Per Share** $-40.95 $-37.22 $-39.08

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.